Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 3 |
2023 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
PD-L1 Activity Is Associated with Partial EMT and Metabolic Reprogramming in Carcinomas.
Curr Oncol. 2022 Oct 31;29(11):8285-8301. doi: 10.3390/curroncol29110654.
Curr Oncol. 2022.
PMID: 36354714
Free PMC article.
Quantifying the Patterns of Metabolic Plasticity and Heterogeneity along the Epithelial-Hybrid-Mesenchymal Spectrum in Cancer.
Muralidharan S, Sahoo S, Saha A, Chandran S, Majumdar SS, Mandal S, Levine H, Jolly MK.
Muralidharan S, et al.
Biomolecules. 2022 Feb 12;12(2):297. doi: 10.3390/biom12020297.
Biomolecules. 2022.
PMID: 35204797
Free PMC article.
Item in Clipboard
Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis.
Pillai M, Rajaram G, Thakur P, Agarwal N, Muralidharan S, Ray A, Barbhaya D, Somarelli JA, Jolly MK.
Pillai M, et al. Among authors: muralidharan s.
Front Oncol. 2022 Aug 8;12:913803. doi: 10.3389/fonc.2022.913803. eCollection 2022.
Front Oncol. 2022.
PMID: 36003764
Free PMC article.
Item in Clipboard
A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells.
Sahoo S, Mishra A, Kaur H, Hari K, Muralidharan S, Mandal S, Jolly MK.
Sahoo S, et al. Among authors: muralidharan s.
NAR Cancer. 2021 Jul 9;3(3):zcab027. doi: 10.1093/narcan/zcab027. eCollection 2021 Sep.
NAR Cancer. 2021.
PMID: 34316714
Free PMC article.
Item in Clipboard
Characterizing heterogeneity along EMT and metabolic axes in colorectal cancer reveals underlying consensus molecular subtype-specific trends.
Sehgal M, Ramu S, Vaz JM, Ganapathy YR, Muralidharan S, Venkatraghavan S, Jolly MK.
Sehgal M, et al. Among authors: muralidharan s.
Transl Oncol. 2024 Feb;40:101845. doi: 10.1016/j.tranon.2023.101845. Epub 2023 Nov 28.
Transl Oncol. 2024.
PMID: 38029508
Free PMC article.
Item in Clipboard
Cite
Cite